| The White House “secured commitments from major healthcare and information technology firms – including Amazon, Anthropic, Apple, Google, and OpenAI” to build a health data sharing system with two main goals: “promoting a CMS Interoperability Framework to easily and seamlessly share information between patients and providers, and increasing the availability of personalized tools so that patients have the information and resources they need to make better health decisions.”
More than 60 companies have pledged support so far, including Microsoft, CVS, UnitedHealth Group, Samsung, and Humana. See press release here.
Next, please see this excellent article from Brownstone: Origins of Medical Harm Although advances in biomedicine have strengthened the ability of physicians to combat some diseases and effectively face emergencies, the guiding compassionate principles of medical care have, for the most part, been lost.
Lastly, ICAN has acquired a Department of Defense (DOD) request for proposal related to its self-spreading vaccine program, DARPA INTERCEPT. In addition, Autonomous Therapeutics has published results of a successful test of its self-spreading vaccines in monkeys and is continuing its drive to develop “synthetic immune systems.”
Last year, ICAN made headlines when we uncovered the worrying new threat posed by the U.S. Government’s funding of studies on self-spreading vaccines. ICAN’s attorneys have recently uncovered more information on DARPA’s INTERCEPT Program, which funded research and development of TIPs (therapeutic interfering particles) that would act as “tiny Trojan horses” to carry engineered viruses that can spread from person to person. The INTERCEPT program even planned to develop computer models to predict how TIPs could spread “from an individual cell to an organism to an entire population.”
FOIA records obtained by ICAN reveal the details of a 2016 DOD request for proposal (the first step in the competitive bidding process for federal contracts), stating that the INTERCEPT Program aimed to develop a biological system for replicating “human-like conditions” for the study of “long-term evolutionary dynamics of fast mutating pathogens, diseases and emerging pandemics of interest to DOD.” This contract was eventually awarded to Autonomous Therapeutics, Inc.
ICAN previously reported on Ariel Weinberger and Leor Weinberger, the co-founders of Autonomous Therapeutics. Now, it appears their potentially dangerous technology is gaining momentum. Leor Weinberger published a study that tested TIPs engineered for HIV on rhesus monkeys, and he is moving forward with plans to inject TIPs into terminally ill humans with HIV. This raises grave health and ethical concerns because TIPs would become a permanent part of the patients’ DNA—and could possibly spread to people outside the clinical trial.
ICAN’s legal team continues to work to ensure these technologies will not be used to infect anyone without their consent. ICAN has sued the government for the federal grants and contracts funding Autonomous Therapeutics and has sent a FOIA request for all INTERCEPT program reports. We will keep you posted as we learn more about this concerning “technology.” |